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ABSTRACT 
The growing use of carbon nanotubes (CNTs) in industrial and consumer products raises 
important questions about their environmental fate and impact on prokaryotes. In the 
environment, CNTs are exposed to a variety of conditions (e.g. UV light) that could lead 
to decomposition and changes in their chemical properties. Therefore, the potential 
cytotoxic effect of both pristine and artificially aged carboxyl functionalized single-
walled CNTs at neutral and acidic conditions on Escherichia coli K12 was analyzed 
using a minimal inhibitory concentration (MIC) assay, which also allowed monitoring of 
non-lethal growth effects. However, there were no observable MIC or significant changes 
in growth behavior in E. coli K12 when exposed to pristine or aged CNTs. Exposure to 
pristine CNTs did not appear to influence cell morphology or damage the cells when 
examined by electron microscopy.  In addition, RNA sequencing revealed no observable 
regulatory changes in typical stress response pathways. This is surprising considering that 
previous studies have claimed high cytotoxicity of CNTS, including carboxyl 
functionalized single-walled CNTs. 
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 1 
1 INTRODUCTION 
 
1.1 Overview of Carbon Nanotubes (CNTs)  
Carbon nanotubes (CNTs) are a type of nanoparticle with the potential for many 
technological applications, but also have unknown toxicity. CNTs are cylinders of 
various lengths composed of single layers of carbon, called graphene, and can be single-
walled (SWCNTs) or multi-walled CNTs (MWCNTs) with different chiralities based on 
the graphene structure used in the manufacturing process (Dai 2002; Petersen et al. 
2011). Raw CNTs are synthesized by three main methods: laser vaporization, dc-arc 
discharge, and chemical vapor deposition and of these methods, dc-arc discharge and 
laser vaporization are the preferred methods for producing SWCNTs and tend to be used 
in large scale production (Dai 2002; Puretzky et al. 2000). During synthesis, carbon 
sources (either solid state or gaseous hydrocarbons, depending on the synthesis method) 
are used along with metal catalysts, such as cobalt, yttrium, iron and nickel catalysts, 
which can lead to raw CNTs having metal impurities (Kolosnjaj-Tabi et al. 2012; 
Puretzky et al. 2000; Köhler et al. 2008).    
Raw CNTs are insoluble in aqueous solutions, causing precipitation and clumping 
of the material. However, solubility and dispersion can be improved when they are 
modified with functional groups, such as carboxyl groups (Kolosnjaj-Tabi et al. 2012; 
Chen et al. 2011). There are several routes for functionalization of CNTs, though 
common practices include acid treatment, such as sulfuric and nitric acid, along with heat 
treatment (Chen et al. 2011).  The addition of functional groups to CNTs increase their 
potential applications by allowing them to bind macromolecules (Kolosnjaj-Tabi et al. 
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2012; Chen et al. 2011).  
The industrial and commercial usage of CNTs has increased several fold over the 
past decade, and the research and development of new products incorporating CNT 
materials is swiftly growing. CNTs are used as additives in composite materials, such as 
CNT resins, that are used for a variety of products from wind turbine blades to sporting 
good equipment (De Volder et al. 2013). CNTs have also been used as additives in 
different types of coatings and films, such as protective paints containing MWCNTs, 
which are used in the marine industry and solar cells (De Volder et al. 2013; Köhler et al. 
2008). Recent development of flexible touch screen displays that include SWCNTs have 
the potential to replace traditional indium tin oxide coated displays which are more brittle 
than the SWCNT counterparts (De Volder et al. 2013). Due to their high conductivity, 
stability, and higher energy density per mass unit compared to graphene, SWCNTs have 
been incorporated into the electrodes of lithium ion secondary batteries and greater than 
60% of cell phone and tablet devices on the consumer market that use these types of 
batteries contain CNTs (Köhler et al. 2008). There is also interest in the use of CNTs in 
biosensor and drug delivery systems based on functionalization (De Volder et al. 2013). 
Despite the broad applications of CNTs, many questions remain about environmental and 
human safety, particularly for CNTs that can be directly released into the environment or 
come in direct contact with humans.  
 
1.2 Current State of CNT Toxicity and Comparisons to Other Nanoparticles  
Over the past several years many studies have been published in regards to CNTs 
and their potential effects and cytotoxicity, with a specific focus on human health 
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impacts. Significant decreases in cell viability and overall cytotoxic effects of SWCNTs 
in eukaryotic cell lines have been reported with exposure to concentrations at and above 
100 µg/mL, and cytotoxic effects reported as reduced phagocytosis activities in alveolar 
macrophage cell lines after exposure to concentrations as low as 0.38 µg/mL (Lewinski et 
al. 2008; Jia et al. 2005). It has been reported that functionalization of SWCNTs can 
affect the observed cytotoxicity in human cell lines, with a higher degree of 
functionalization in a SWCNT product correlating with a lower observed percent cell 
death (Sayes et al. 2006). In addition, functionalized SWCNTs, including those with 
carboxyl groups, have been reported to have no significant cytotoxic effects in human 
cell lines in comparison to non-functionalized SWCNTs (Kam et al. 2004). Since CNTs 
are particles with similar physical characteristics to asbestos, the toxic effects of these 
two particles have been compared. Indeed some MWCNTs have been shown to cause 
comparable damage to human bronchial epithelia cells lines as asbestos (Kim et al. 
2012).  
Antibacterial properties of CNTs have been shown to be dependent on the various 
physicochemical characteristics of the CNTS, including length, diameter, and functional 
groups, as well as the type of bacteria being tested. SWCNTs have demonstrated 
antimicrobial affects by damaging bacterial cell membranes (Kang et al. 2007). 
Additionally, non-functionalized SWCNTs with diameters ranging from 1.04- 1.17 nm 
have been shown to cause damage to bacterial cell walls via piercing, which can lead to 
loss of cellular contents and cell death (Kang et al. 2007; Liu et al. 2009; Chen 2013). 
Coccoid bacteria with spherical morphology have been shown to be more susceptible to 
cellular damage and have lower survival rates in comparison to bacilli under the same 
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treatment conditions (Chen et al. 2013). It has been suggested gram positive bacteria are 
more susceptible to SWCNT damage (Liu et al. 2009), although the exact concentration 
of carboxyl-functionalized SWCNTs that inhibit bacterial growth in model bacterial 
organisms has yet to be adequately evaluated. 
 
1.3 Environmental Life Cycle Assessment 
Materials within the nanoscale range have high surface area as well as chemical 
and physical properties that differ from the same type of bulk material, which lends to the 
question of potential impacts for humans and ecosystems from nanomaterials like CNTs 
(US EPA 2010; Reinhart et al. 2010). Current standards and regulations on nanoparticles 
usually relate back to the bulk material properties since the United States Environmental 
Protection Agency (EPA) does not consider the particle size, only the molecular 
composition in their regulatory inventory list (US EPA 2008).  CNTs are considered 
chemicals with a unique molecular identity under the Toxic Substances Control Act 
(TSCA), and as of 2013 the EPA has implemented a significant new use rule (SNUR) 
under the TSCA which specifically refers to CNTs (US EPA 2008; US EPA 2015). This 
SNUR allows the EPA to track and review chemicals before manufacturing or importing 
and make decisions based on potential impacts to human and ecosystems, and 
specifically cites concerns about chemicals generically identified as functionalized 
MWCNTs (US EPA 2015).  
The EPA recognizes the need for further research on the impact of nanoparticles, 
including different classes of CNTs. One route that is of interest is a lifecycle analysis, 
which looks at impacts of a chemical and potential release points from production of the 
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raw materials, use in products, end of life recycling and disposal methods, and waste 
produced at any step in the life cycle (US EPA 2010; Köhler et al. 2008). As part of a 
lifecycle analysis it is important to consider how a chemical is incorporated into products, 
various environmental conditions that a chemical may experience, and also the impacts 
on organisms within potentially affected ecosystems. The effect of CNTs on the growth 
and viability on the environmental bacterial community is a key part of an environmental 
life cycle assessment of chemicals as bacteria are the most important biological factor in 
nutrient cycling. 
When materials are deposited in the environment they are exposed to weathering 
processes that can be mimicked with the use of a UV accelerated weathering chamber 
(Grujicic et al. 2003). UV-light exposure has been shown to cause physical changes in 
CNT shape and chemical changes, including changes in the way oxygen associates with 
the carbon nanotube wall surfaces (Grujicic et al. 2003). The alterations in physical and 
chemical properties of aged CNTs lends to the question of whether environmental 
induced changes could affect cytotoxicity of CNTs. However, no studies on the effects of 
aged carboxyl functionalized SWCNTs on bacterial cytotoxicity have been done to date. 
 
1.4 Determination of Cytotoxicity and Non-Lethal Effects of CNTs 
The growth behavior, metabolism, and gene regulation of the model organism 
Escherichia coli K12 is well established, which makes it a common first choice microbe 
for cytotoxicology studies. It is predicted that exposure to pristine or aged carboxyl 
functionalized SWCNTs will have deleterious growth effects on E. coli K12 if they are 
cytotoxic. In this study, the ability of pristine and aged carboxyl functionalized SWCNTs 
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to inhibit E. coli K12 growth or cause cell death was monitored by a minimal inhibitory 
concentration (MIC) assays using a range of CNT concentrations using the CNTrene® 
C100LM SWCNT supplied by Brewer Science. The change in cell viability of E. coli 
K12 after exposure to concentrations of pristine carboxyl functionalized SWCNTs greater 
than 1.05 µg/mL was monitored by antibacterial plate testing. The effect of exposure to 
non-lethal concentrations of carboxyl-functionalized SWCNTs on cell morphology was 
evaluated by electron microscopy. Gene expression of E. coli K12 cells post CNT 
exposure was evaluated and compared to native gene expression by RNA sequencing. 
These results are expected to provide insights into the microbiological safety of this 
product that is potentially useful in commercial products such as advanced memory 
devices for computers, tablets, smart phones, and digital cameras.  
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2 MATERIALS AND METHODS 
 
2.1 Bacteria and Media 
Escherichia coli K12 strain SMG 123 (PTA7555) was grown in lysogeny broth 
(LB), which is a rich bacteriological medium, as well as M9 minimal salts medium with 
the addition of thiamine (M9+B1), which is a minimal medium that has no free proteins 
in solution. E. coli was grown at 37 °C and 200 rpm in a Thermo Scientific MaxQ 400 
incubator shaker unless stated otherwise. 
Lysogeny broth (LB) 
Tryptone 10 g 
Yeast Extract 5 g 
NaCl 10 g 
H2Odist Add to 1000 mL 
For plates 15g agar was added to the medium prior to autoclaving 
 
5X M9 Stock  
Na2HPO4 7H2O   
KH2PO 
64 g 
15 g 
 
NaCl 2.5 g  
NH4Cl 5 g  
H2Odist Add to 1000 mL  
 
 
1X M9 Solution 
5X M9 stock 
H2Odist 
200 mL 
Add to 1000 mL 
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M9 Minimal Medium (M9+B1) 
1X M9 solution 1000 mL 
1M MgSO4 (filter sterilized) 2 mL 
20% (w/v) glucose (filter sterilized) 
1M CaCl2 (filter sterilized) 
20 mL 
100 µL 
1M Thiamine (filter sterilized)  1 mL 
1X M9 solution was autoclaved prior to adding filter sterilized components 
  
2.2 Carbon Nanotubes 
 CNTrene® C100LM carbon nanotubes (CNTs) were supplied by Brewer 
Scientific. CNTrene® C100LM is a pristine, carboxyl functionalized single-walled carbon 
nanotube (SWCNT) product suspended in water at a concentration of 135 µg/mL.  
CNTrene® C100LM has a length range of 0.4- 1.5 µm (90% of CNTs), a diameter range 
of 0.7- 3 nm (95% of CNTs), and a total metal ion content of less than 25 ppb (R. Patel, 
unpublished data). The pristine product is made up of SWCNT, DWCNT, and MWCNT 
at 70%, 25%, and 5% respectively (R. Patel, unpublished data). Pristine CNTs were aged 
in a QUV Accelerated Weathering chamber using a wavelength of 340 nm for 120 hours 
of direct exposure to simulate UV-A exposure. Aged CNTs were a generous gift from Dr. 
Adam Waynekaya (Missouri State University, Chemistry Department). Both pristine and 
aged CNTs were serially diluted in growth medium to final concentrations ranging from 
33.75 µg/mL to 6.44 x 10-5 µg/mL for cytotoxicity assays.   
 
2.3 Minimal Inhibitory Concentration (MIC) 
A MIC assay was used to determine the minimum concentration of CNTs that 
completely inhibit the growth of E. coli K12 in liquid medium. To standardize the 
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inoculum used for MIC assays, preliminary standard plate counts were used to determine 
the colony forming units per milliliter (CFU/mL) of E. coli K12 in 100 mL of neutral (pH 
7) growth medium (either LB or M9+B1) after an 18-20 hour incubation period at 37 oC 
at 200 rpm in a Brunswick Scientific G24 environmental incubator shaker. The calculated 
CFU/mL were also related back to the average OD600nm (Shimadzu UV-1601 
spectrophotometer) measured for the E. coli K12 cultures used for standard plate counts, 
which allowed for cultures to be verified before use for as standard inoculum in MIC 
assays. Once the average CFU/mL was determined for both types of growth media, the 
final cell number added to each assay was adjusted to a standard inoculum of 5.00 x 105 
CFU/mL, which was calculated based on the following formula: 
C1V1= C2V2 
In the above equation, C1 is initial concentration of bacterial cells, V1 is the volume of C1 
being used for the dilution, C2 is the target concentration of bacterial cells, and V2 is the 
final volume of the culture including V1.  
A broth micro dilution MIC assay on a 96-well transparent C-bottom plate was 
performed with a standard inoculum of 5.00 x 105 CFU/mL (based on preliminary 
standard plate counts) in a final reaction volume of 200 µL (Wiegand et al. 2008). 
Medium used included LB under neutral and acidic conditions (pH 7 and pH 5 
respectively) as well as M9+B1 at neutral conditions (pH 7). A BioTek EL808 plate 
reader was used to monitor optical density at 595 nm (OD595). Plates were incubated at 37 
oC at the medium shake rate of the instrument for 24 hours with OD595 readings taken 
every 30 minutes. The Gen5 software was used for data collection.  
Each plate had a negative control in column 12, with only growth medium to 
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validate sterility during plate setup and inoculation (Figure 1). In column 11 a positive 
control with growth medium inoculated with E. coli K12 was used as a normal growth 
comparator. Row A and row E were CNTs blanks, comprised of growth medium and 
CNT dilutions, which allowed correction of the intrinsic CNT background absorbance. 
Experimental wells were inoculated with E. coli K12 and contained CNT dilutions from 
33.77 µg/ml to 6.44 x 10-5 µg/ml and were assayed in triplicate. Each CNT dilution was 
also assayed with three biological replicates (n=9).  
Growth curves were generated by monitoring OD595nm. Doubling times (td) were 
calculated based on the following formulas:  
(1) N = No2n ; where N is the final OD at time t, No is the initial OD, and n is the 
number of generations per unit time. 
(2) Rearrangement of (1) gives: n = log (N/No) / 0.301 
(3) td = t/n or n =t/td ; where td is doubling time  
(4) substituting (2) for (3) gives: td = 0.301t / (log N – log No) 
Growth curves and doubling times were used to evaluate nonlethal growth effects of 
CNT exposure.  
 
2.4 Antibacterial Plate Counts  
The effect of pristine CNT concentrations greater than 5 µg/mL on the growth of 
E. coli K12 was evaluated by the spot-plate technique using a modified method of Gaudy 
et. al., 1963. E. coli K12 cultures were inoculated in 96-well transparent C-bottom plates 
with LB (pH 7) and pristine CNTs (0 µg/mL, 8.44 µg/mL, 16.88 µg/mL, and 33.75 
µg/mL) in triplicate to a final volume of 200 µL and incubated for 24 hours at 30 oC and 
 11 
200 RPM in a Lab-Line 3525 orbit incubator shaker. Serial ten-fold dilutions of overnight 
cultures were performed on 96-well plates and 10 µl of the 10-5, 10-6, and 10-7 dilutions 
were spotted in triplicate on LB plates and incubated at 30 oC for 16-18 hours. Colony 
forming units per milliliter (CFUs/mL) were calculated for each concentration of CNTs 
and compared to that of the unexposed control group.  
 
2.5 Electron Microscopy 
Morphological change of bacterial cells exposed to CNTs was evaluated by 
scanning electron microscopy (SEM) and atomic force microscopy (AFM). A serial ten-
fold dilution of an overnight 5 mL LB (pH 7) culture of E. coli K12 was performed, and 
100 µL from the 10-3 dilution was used to inoculate LB (pH 7) in a final volume of 200 
µl in a 96-well transparent C-bottom plate. Medium also contained 0 µg/mL, 33.75 
µg/mL, 16.88 µg/mL, and 1.05 µg/mL pristine CNTs. E. coli K12 was grown at each 
CNT concentration in triplicate for 24 hours.  All electron microscopy sample preparation 
steps were done at room temperature. Replicates were combined, pelleted by 
centrifugation at 5000 x g for 5 minutes, and then washed three times in 0.1 M phosphate 
buffer (pH 7.2) to remove growth medium. Cells were dehydrated by an ascending 
ethanol wash series (50%, 70%, 80%, 90%, 95%, 100%, and 100%) with a 5 minute 
exposure to each concentration of ethanol. Samples were transferred onto silicon wafers 
in 10 µL volumes and either frozen in liquid nitrogen and freeze dried overnight for SEM 
or allowed to air dry overnight for AFM.   
Prepared samples were visualized on instruments located at the Jordan Valley 
Innovation Center by Rishi Patel. Samples were visualized with the JEOL JSM-7600F 
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field emission scanning electron microscope under vacuum (9.6 x 10-5 Pascal). SEM 
images were captured using an accelerating voltage of 1.00 kV and a working distance 
(WD) between 5.1 mm and 5.2 mm at total magnification ranging from 10,000x to 
20,000x. AFM imagines were captured utilizing the Veeco Dimension 3100 with a 
Nanoscope IIIA Controller under atmospheric conditions (1.01 x 105 Pascal). AFM 
imagines were captured on tapping mode (scan size 5.000 µm or 20.0 µm, scan rate 1.001 
Hz, 512 samples) using a silicon tip with a nominal radius of 8.0 nm. 
 
2.6 RNA Sequencing 
Gene expression of CNT exposed bacterial cells was evaluated with RNA 
sequencing and compared to native gene expression. The RNeasy Plus Mini Kit (Qiagen, 
Venlo, Netherlands) recommends the use of minimal medium for culturing bacteria. Fifty 
microliters from overnight cultures of E. coli K12 in 5 mL of M9+B1 was inoculated into 
5 mL of M9+B1 medium in disposable 16 mL culture tubes.  Pristine CNTrene® 
C100LM was added to 1.05 µg/mL to experimental cultures. Bacterial cultures were 
incubated for 6 hours to mid-log phase with each sample grown in duplicate. The RNeasy 
Plus Mini Kit (Qiagen) was used to extract RNA from 2 mL of culture with one on-
column treatment with the RNase-Free DNase Set (Qiagen) according to the 
manufacturer’s instructions.  RNA extractions were carried out in duplicate for each 
culture.  
RNA concentrations were evaluated using the IMPLEN nanophotometer (RNA 
function, lid factor 10, 2 µL sample). To confirm samples were of high quality, the RNA 
was also analyzed with an Agilent Technologies 2100 Bioanalyzer system and 2100 
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Expert software (Dr. Wenping Qiu, Missouri State University, Agriculture Department). 
Samples were concentrated by evaporation at room temperature overnight in a class 2 A 
laminar flow hood to provide sufficient volume and concentration required for ribosomal 
depletion.  
Ribosomal depletion was done using the bacterial Ribo-Zero rRNA Removal Kit 
(Illumina, San Diego, Ca, USA) according to the manufacturer’s instructions.  The 
SMARTer Stranded RNA-Seq kit (Clontech, Mountain View, Ca, USA) was used to 
prepare cDNA from high quality RNA samples according to the manufacturer’s 
instructions. An Illumina MiSeq instrument (single-end 50 base pair read length) was 
used for RNA sequencing. Sequencing data was analyzed using the DNAstar Lasergene 
Suite Qseq software (http://www.dnastar.com). The sequence reads were mapped and 
analyzed using the RNA-Seq pipeline default parameters using E. coli K12 MG1655 as a 
reference genome.  
 
2.7 Waste Handling 
All waste that came in contact with CNTrene® C100LM materials, including 
bacterial cultures, were collected by Environmental Management and processed as 
hazardous material. Liquid waste was stored in a labeled glass container in a ventilation 
hood until collected for processing. Solid waste was double bagged (e.g. 96 well plates, 
gloves, and microcentrifuge tubes) and sealed in in a bag-lined 5 gallon bucket with a 
screw-top lid until waste collection by Missouri State University Environmental 
Management.   
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2.8 Data Analysis 
Comparison of doubling times calculated from growth curves were evaluated by 
Pearson’s correlation coefficient using Social Science Statistics using p = 0.01 as 
threshold for statistical significance (Jeremy Stangroom ©2015, URL 
http://www.socscistatistics.com), as well as regression analysis using GraphPad Prism 5 
software (GraphPad Software Inc. ©2015, La Jolla, CA). Evaluation of differences in 
CFU/mL from antibacterial plate testing was done by unpaired t-test (two-tailed p-value 
with 95% confidence levels) using Quick Calc GraphPad software (GraphPad Software 
Inc. ©2015). All graphs were generated using Microsoft Excel, with the exception of the 
box-whisker plot, which was generated using the R programming language (R Core 
Team, 2013).  RNA sequencing data was analyzed using the student t-test with the false 
discovery rate restricted to 0.05 using the Benjamini Hochberg method as the P-value 
adjustment method (Benjamini and Hochberg 1995). 
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3 RESULTS 
 
3.1 MIC Assays of E. coli K12 under Various Growth Conditions 
Based on OD595nm readings, a MIC value can be determined for each type of CNT 
for E. coli K12 under various growth conditions. A MIC value is the lowest concentration 
of the CNT treatment that completely inhibits bacterial growth, which would be seen as 
no change in optical density readings during the duration of the incubation period.   
To standardize the inoculum used for the MIC microplate assays, the cell number 
had to be correlated to the colony forming units produced per milliliter of culture 
(CFU/mL). This was done by using a standard plate count for E. coli K12 grown in LB or 
M9+B1 at a neutral pH. After 18-20 hours of growth, the CFU/mL were correlated to the 
average OD600nm of each media type. E. coli K12 cultures grown in LB (pH 7) medium 
had an average of 5.02 x 109 (± 1.34 x 109) CFU/mL at an average OD600nm of 2.32 (± 
0.03). A lower optical density (0.95 ± 0.07) and cell number (6.13 x 108 ± 2.61 x 108) 
was observed when E. coli K12 was grown in M9+B1 medium, pH 7. Once the average 
CFU/mL was determined for both types of growth media, the final cell number added to 
each MIC assay was adjusted to a standard inoculum of 5.00 x 105 CFU/mL. 
 Growth curves for E. coli K12 were generated by plotting the natural logarithm 
of the OD595nm over a 24 hour period. Microtiter wells containing only growth medium 
and either pristine or aged CNTrene® C100LM at each treatment concentrations were 
subtracted from their respective data sets to normalize bacterial growth for intrinsic 
absorbance of the media and/or the CNTs. Doubling times were calculated as previously 
described (see section 2.3) for E. coli K12 under various growth conditions.  Due to 
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significant optical interference from CNTrene® C100LM at concentrations higher than 
1.05 µg/mL, only exposure to concentrations ranging from 6.44 x 10-5 µg/mL to 1.05 
µg/mL were considered in doubling time calculations. 
Growth curves for E. coli K12 in LB (pH 7) in the presence of pristine CNTs over 
the tested concentration range were very similar to the growth observed in the control 
groups, with all growth curves overlapping (Figure 2-3). The same trend was observed 
for E. coli K12 in LB (pH 7) in the presence of aged CNTs, with growth curves for 
controls and treatment groups overlaying (Figure 4-5). Cultures in LB (pH 7) had 
doubling times ranging from 21.4 min to 26.1 min (± ≤ 1.7 min) after exposure to pristine 
CNTs, and doubling times ranging from 20.9 min to 24.1 min (± ≤ 1.6 min) when 
exposed to aged CNTs (Figure 6). In comparison, control groups in the pristine and aged 
CNT assays had doubling times of 23.2 min (± 0.7 min) and 22.2 min (±0.5 min) 
respectively with an overall average of 22.7 min (± 0.8 min) (Figure 6). Even the highest 
doubling time observed at 26.1 min (± 1.2 min) (1.05 µg/mL pristine CNT) was still 
within 3.4 min of the overall doubling time for the control groups. 
Doubling times observed for E. coli K12 in LB (pH 7) were similar between 
pristine and aged CNTs at the same treatment concentrations, with percent differences 
ranging from 0.8% to 5.8%, with the exception of the 1.05 µg/mL and 5.15 x 10-4 µg/mL 
concentrations (13.6% and 9.7% respectively) (Table 1). The percent difference between 
controls from the pristine CNT assays and the aged CNT assays was 4.5%, indicating that 
the differences observed between pristine and aged CNTs was within typical 
experimental deviation (Table 1). There was a moderate positive correlation between 
pristine CNT concentration and doubling time in E. coli K12 growth in LB (pH 7) (p = 
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0.000148, R2 = 0.276). However, only 27.6% of the variation was explained by the CNT 
concentrations tested, and no correlation was observed when the highest pristine CNT 
concentration (1.05 µg/mL) was omitted from the analysis (p = 0.357281, Pearson 
correlation coefficient) (Figure 7). These data suggest that the observed increase in 
doubling time may be due to minor intrinsic optical interference in optical density 
measurements, likely due to the CNTs being black and having a tendency to flocculate. In 
contrast, there was no significant correlation between the concentration of aged CNTs 
and doubling time under the same conditions (p = 0.081, Pearson correlation coefficient) 
(Figure 7).  
Growth curves for E. coli K12 in M9+B1 minimal medium in the presence of 
either pristine or aged CNTs over the tested concentration range were very similar to the 
growth observed in the control groups, with all growth curves in both data sets 
overlapping (Figure 8-11). Since M9+B1 is a minimal medium, observed doubling times 
were higher than those observed in the nutrient rich LB medium. Control groups in the 
pristine and aged CNT assays had doubling times of 60.9 min (± 0.6 min) and 60.3 min 
(± 1.0 min) respectively with an overall average of 60.7 min (± 0.7 min) among control 
groups (Figure 12). E. coli K12 cultures in M9+B1 that were exposed to CNTs had 
similar doubling times. Doubling times ranged from 59.2 min to 61.8 min (≤± 4.9 min) in 
the presence of pristine CNTs, and 58.7 min to 60.6 min (≤± 2.0 min) when exposed to 
aged CNTs (Figure 12).  
The doubling times observed for E. coli K12 in M9+B1 were very similar 
between pristine and aged CNTs at the same treatment concentrations, with percent 
difference ranging from 0.3% to 4.0%, which was comparable to the percent difference of 
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1.0% observed between the controls from the pristine CNT and the aged CNT assays 
(Table 1).There was no significant correlation between the concentration of pristine 
CNTs and doubling time of E. coli K12 in M9+B1 medium (p = 0.941385, Pearson 
correlation coefficient) (Figure 13). Similarly, there was no significant correlation 
between the concentration of aged CNTs and doubling time (p = 0.138074, Pearson 
correlation coefficient).  
Growth curves for E. coli K12 in LB (pH 5) in the presence of either pristine or 
aged CNTs over the tested concentration range were very similar to the growth observed 
in the control groups, with all growth curves in both data sets superimposing (Figure 14-
15). Control groups in the pristine and aged CNT assays had doubling times of 30.1 min 
(± 1.0 min) and 29.1 min (± 0.1 min) respectively with an overall average of 29.5 min (± 
0.7 min) among control groups (Figure 16). E. coli K12 cultures in LB (pH 5) that were 
exposed to either pristine or aged CNTs had doubling times ranging from 30.1 min to 
31.7 min (≤± 1.5 min) and from 28.9 min to 31.5 min (≤± 1.3 min) respectively (Figure 
16).  
The doubling times observed for E. coli K12 in LB (pH 5) were very similar 
between pristine and aged CNTs at the same treatment concentrations, with percent 
difference ranging from 0.7% to 5.9% (Table 1). The percent difference between the 
controls from the pristine CNT and the aged CNT assays was 3.3% (Table 1). There was 
no significant correlation between the concentration of pristine CNTs and doubling time 
of E. coli K12 in LB (pH 5) medium (p = 0.024581, Pearson correlation coefficient) 
(Figure 17). In contrast, there was a significant correlation between the concentration of 
aged CNTs and doubling time under the same conditions (p = 0.000031, Pearson 
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correlation coefficient) (Figure 17). This is surprising since the percent difference 
between doubling times observed after pristine or aged CNT exposure was at most 5.9%, 
which was less than a two-fold increase of the percent difference observed between 
controls (3.3%). Furthermore, doubling times were only slightly increased (2.4 min 
longer) than the unexposed control, indicating that differences observed may be due to 
random experimental variation of the assay used.  
 
3.2 Antibacterial Plate Counts 
Significant optical interference was observed at CNT concentrations over 1.05 
µg/mL, making MIC microtiter assays infeasible. Therefore, growth effects of pristine 
CNTs at concentrations higher than 1.05 µg/mL on E. coli K12 were evaluated by a 
modified spot plate technique (see section 2.6). The CFU/mL were calculated after 24 
hours of exposure to pristine CNTs at final concentrations of 0 µg/mL (control), 8.44 
µg/mL, 16.88 µg/mL, and 33.75 µg/mL. The calculated CFU/mL were 2.04 x 109 
CFU/mL (± 4.63 x 108 CFU/mL, n = 8), 1.26 x 109 CFU/mL (± 3.72 x 108 CFU/mL, n = 
11), 1.39 x 109 CFU/mL (± 2.85 x 108 CFU/mL, n = 8), and 1.37 x 109 CFU/mL (± 3.44 
x 108 CFU/mL, n = 11), respectively (Figure 18). The colony forming units for E. coli 
K12 exposed to each treatment concentration of CNTs (8.44 µg/mL, 16.88 µg/mL, and 
33.75 µg/mL) were found to be significantly different from the control group (p = 0.0008, 
p = 0.0045 and p = 0.0021; unpaired two-tailed t-test), respectively. Although these p-
values suggest that there is a significant difference between the control and treatment 
groups, the difference was less than or equal to a 1.61-fold reduction in CFU/mL among 
the three treatment conditions. Furthermore, a linear regression of these data does not 
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significantly deviate from zero (p = 0.4031). Taken together, these data imply that there 
is no true biological significance in the slight reduction in CFU/mL when E. coli is 
exposed to up to 33.75 µg/mL CNTs.    
 
3.3 Electron Microscopy Imagining  
Morphological changes of E. coli K12 exposed to pristine CNTs at concentrations 
at and above 1.05 µg/mL were evaluated by electron microscopy. With SEM, control 
cells visualized at 10,000x and 25,000x appeared as morphologically normal bacilli, with 
intact outer membranes and lengths ranging between 1 µm and 2 µm (Figure 19). After 
24 hour exposure to pristine CNTs (33.75 µg/mL and 16.88 µg/mL), cells had similar 
morphologies to control samples. The E. coli were  within the typical 1 µm to 2 µm 
length range and had normal intact outer membranes, and physical damage caused by 
CNT exposure was not observed  (Figure 19).  
Three dimensional AFM images were generated by the Veeco Dimension 3100 
with a Nanoscope IIIA Controller using tapping mode (scan size 5.000 µm or 20.0 µm; 
scan rate 1.001 Hz, 512 samples) and a silicon tip (radius of 8.0 nm) under atmospheric 
conditions. As was observed with SEM, AFM images of control E. coli K12 cells 
appeared as morphologically normal bacilli with intact outer membranes, lengths 
between 1 µm to 2 µm, and diameters of 0.5 µm (Figure 20-21). After 24 hour exposure 
to pristine CNTs (33.75 µg/mL, 16.88 µg/mL, and 1.05 µg/mL), cells had normal 
morphological features including cell length and diameter (1 µm – 2 µm and 0.5 µm, 
respectively), similar to control cells (Figure 20-21). 
In SEM images, CNTs were primarily observed to be adjacent to bacterial cells 
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and not in direct contact with the cell surface. Although, some CNTs were in direct 
contact with outer membranes of the cells, yet no damage to outer membranes, such as 
physical puncturing, was observed.  Due to the resolution restrictions of the instrument, 
no CNT structures could be positively identified in AFM images, so no association 
between cells and CNTs was directly observed. However, cells appeared intact, without 
abnormalities in cell morphology, which corresponds to the SEM images. Taken together, 
these data suggest that the CNTs are do not physically damaging E. coli. 
 
3.4 RNA Sequencing  
RNA sequencing was carried out for E. coli K12 cultures grown to mid-log phase 
in M9+B1 minimal medium, with experimental cultures exposed to pristine CNTs at a 
concentration of 1.05 µg/mL and compared to control cultures without CNT exposure. 
RNA extracts were analyzed with an IMPLEN nanophotometer and an Agilent 
Technologies 2100 Bioanalyzer system. Total RNA concentrations of samples ranged 
from 14 ng/µL to 22 ng/µL when evaluated with the nanophotometer. RNA 
concentrations largely agreed when analyzed with the Bioanalyzer, and were all 
determined to be between 10 ng/µL to 16 ng/µL using this system (Table 2). 
Electropherograms from the Bioanalyzer showed strong peaks corresponding to 16S 
rRNA and 23S rRNA regions and were centered around 40 seconds and 45 seconds, 
respectively (Figure 22). The 16S and 23S rRNA migrated to the expected size according 
to the simulated Bioanalyzer gel images. The ratio of the 16S and 23S rRNA areas were 
used by the 2100 Expert Software to determine the RNA integrity number (RIN) of the 
sample. An RIN with a value greater than or equal to 8 was considered high quality and 
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suitable for library construction (Agilent, 2005). All RNA extracts had rRNA ratios 
(16S/23S) ranging from 1.4 to 1.8 with RIN values ranging from 8.9 to 9.3 (Table 2). 
Taken together, these data indicated that the total RNA preparations were not degraded 
and of high quality, suitable for RNA-seq library preparation.  
After ribosomal depletion, RNA samples were again evaluated with an Agilent 
Technologies 2100 Bioanalyzer system to confirm rRNA was significantly reduced to 
increase reads aligning to coding mRNA, as around 80% of total RNA may be rRNA in 
E. coli (Giannoukos et al. 2012). Depleted RNA concentrations ranged from 170 pg/µL 
to 753 pg/µL, with rRNA contamination percentages ranging from 0.4% to 15.3% (Table 
2). These data confirmed that rRNA was significantly depleted prior to library 
preparation and sequencing. 
Control samples one through three had total aligned sequence reads of 1,898,979 
reads, 2,154,777 reads, and 2,546,169 reads, respectively. Similarly, experimental 
samples one through three exposed to 1.05 µg/mL of pristine CNTs had total aligned 
sequence reads of 2,492,925 reads, 2,434,573 reads, and 2,849,043 reads, respectively. 
All control and experimental samples had sequence lengths of 35-51 bp with a GC 
content of approximately 54%, closely mirroring the genomic GC percentage of 50.8% 
(Riley et al. 2005). Gene expression of E. coli K12 exposed to pristine CNTs was 
compared to native gene expression with the E. coli K12 MG1655 reference genome used 
for mapping sequencing reads.  Of the 4464 open reading frames (ORFs) (NCBI 
accession NC_000913), 4314 genes were mapped indicating that 96.6% of all genes were 
expressed. Of the 4314 genes mapped, 186 genes were differentially expressed using a 2-
fold change between control and experimental samples as a threshold. Of these 186 
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genes, 26 genes were upregulated in the experimental CNT exposed samples, and 160 
genes were downregulated (Figure 23). However, only three genes (pptA, alpA, and 
mgtL) were expressed at a significantly different level in the experimental samples after 
correcting for false discovery rate of 0.05 using the Benjamini-Hochberg method 
(Benjamini and Hochberg 1995). The pptA and alpA genes were considered significantly 
downregulated with a 2.5-fold change (p = 0.0272) and 35.1-fold change (p = 0.0227), 
respectively. The mgtL gene was the only gene to be upregulated, with an 85.3-fold 
increase in expression in experimental samples (p = 1.87 x 10-7) (Table 3).  
The pptA gene (COG 1942) is predicted to encode a 4-oxalocrotonate tautomerase 
that functions in degradation pathways for xenobiotic aromatic compounds (Kanehisa and 
Goto 2000). The alpA gene (COG 3311) is prophage regulatory protein that is part of a 
group of DNA transcription regulators within the MerR superfamily, and regulators 
within this family have been shown to regulate in response to environmental stressors, 
such as heavy metals (Marchler-Bauer et al. 2015). The genes downstream of this ORF 
encode proteins associated with the cryptic prophage CP4-57. The mgtL gene acts as a 
leader sequence to the downstream mgtA gene (COG 0474) which is a Mg2+ transport 
protein (Park et al. 2010). The mgtL leader sequence serves a riboswitch for the Mg2+ 
porin, which allows expression of the porin to be regulated by the availability of proline 
and Mg2+ (Park et al. 2010).  
 Of these 3 genes, the pptA gene regulation was very close to the 2-fold change 
threshold and may not actually be differentially expressed. Therefore this genes should be 
verified by quantitative polymerase chain reaction (qPCR) to validate if is truly 
downregulated or the differential expression is due to experimental variation. Only the 
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alpA and mgtL genes showed high levels of differential expression after CNT exposure. 
Regardless, the role of all three genes identified by RNA-seq in response to CNT 
exposure is unclear as all three genes have dissimilar function and are not part of a 
general stress response that would be expected from physical interaction or cell envelope 
damage.   
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Table 1. Percent differences between doubling times for E. coli K12 exposed to either 
pristine or aged CNTrene® C100LM for 24 hours 
 
  % Difference* 
CNT(µg/mL) LB (pH 7) LB (pH 5) M9+B1 
0 (Control) 4.5% 3.3% 1.0% 
6.44 x 10-5 1.5% 4.4% 0.4% 
1.29 x 10-4 5.8% ND 0.6% 
2.57 x 10-4 1.4% 2.0% 0.8% 
5.15 x 10-4 9.7% ND 1.2% 
1.03 x 10-3 1.8% 5.9% 1.7% 
2.06 x 10-3 0.8% ND 1.3% 
4.12 x 10-3 2.8% 2.9% 1.1% 
8.24 x 10-3 3.6% ND 1.0% 
1.65 x 10-2 3.9% 3.9% 0.3% 
3.30 x 10-2 2.9% ND 1.0% 
6.59 x 10-2 2.2% 5.0% 3.4% 
0.13 4.0% 2.5% 2.2% 
0.26 1.8% 2.7% 3.0% 
0.53 0.9% 0.7% 4.0% 
1.05 13.6% 0.9% 0.4% 
 
* Percent difference for CNT treatment samples was calculated by comparison between 
pristine and aged treatment groups; Percent difference for controls was calculated by 
comparison of independent control samples between the pristine and aged assay plates. 
ND, not determined for the concentration of CNTrene® C100LM in the specified growth 
medium 
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Table 2. RNA extracted from E. coli K12 quality control analysis   
      Total RNA (ng/µL)     
Sample RIN 
rRNA 
ratio 
[23s/16s] 
Nano- 
photometer Bioanalyzer 
rRNA 
Depleted 
 RNA  
(pg/µL)  
rRNA 
contamination 
Control 1 9 1.4 14 13 170 0.4% 
Control 2 8.9 1.6 22 15 211 3.4% 
Control 3 9.2 1.6 15 14 499 2.5% 
CNT 1  8.9 1.6 16 16 753 15.3% 
CNT 2 9.2 1.6 14 11 407 8.3% 
CNT 3 9.3 1.8 16 10 740 10.7% 
 
RIN, RNA integrity number from Agilent 2100 Bioanalyzer  
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Table 3. Comparative gene expression in E. coli K12 based on RNA sequencing 
      Standard deviation    
Gene 
name COG 
Fold Change 
(experimental/ 
control) Control Experimental P-value 
mgtL 0474* 85.3 up 0.0 0.053 1.87 x10-7 
alpA 3311 35.1 down 0.816 0.0 0.0227 
pptA 1942 2.5 down 0.172 0.138 0.0272 
 
COG, Clusters of orthologous groups of proteins 
* COG number for mgtA gene provided as mgtL is as a leader sequence for mgtA and 
does not belong to a COG family.  
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Figure 7. E. coli K12 doubling times at CNTrene® C100LM treatment concentrations in 
LB pH 7. (A) Pristine CNTrene® C100LM doubling times. Pearson correlation 
coefficient, R2 = 0.2764; significant moderate positive correlation (p = 0.000148). Inset, 
identical data omitting the 1.05 µg/mL CNT concentration. Pearson correlation 
coefficient, R2 = 0.0197; correlation is not significant (p = 0.357281). (B) Aged 
CNTrene® C100LM and doubling times. Pearson correlation coefficient, R2 = 0.0647; 
correlation is not significant (p = 0.081). 
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Figure 13. E. coli K12 doubling times at CNTrene® C100LM treatment concentrations in 
M9+B1. (A) Pristine CNTrene® C100LM doubling times. Pearson correlation coefficient, 
R2 = 0.0001; correlation is not significant (p = 0.941385). (B) Aged CNTrene® C100LM 
and doubling times. Pearson correlation coefficient, R2 = 0.0723; correlation is not 
significant (p = 0.138074). 
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Figure 17. E. coli K12 doubling times at CNTrene® C100LM treatment concentrations in 
LB pH 5. (A) Pristine CNTrene® C100LM doubling times. Pearson correlation 
coefficient, R2 = 0.1574; correlation is not significant (p = 0.024581). (B) Aged 
CNTrene® C100LM and doubling times. Pearson correlation coefficient, R2 = 0.6839; 
significant moderate positive correlation (p = 0.000031). 
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Figure 18. Comparison of colony forming units per mL (CFU/mL) for E. coli K12 after 
24 hour exposure to pristine CNTrene® C100LM at 0 µg/mL (control), 8.44 µg/mL, 
16.88 µg/mL, and 33.75 µg/mL. Each treatment group was compared to the control by 
unpaired t-test (two-tailed p value, 95% confidence levels) and each treatment was found 
to be statistically different from the control (p = 0.0008, p = 0.0045 and p = 0.0021 
respectively). A linear regression does not significantly deviate from zero (p = 0.4031). 
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Figure 19. Scanning electron microscopy (SEM) images of E. coli K12 after 24 hour 
exposure to pristine CNTrene® C100LM. Images from JEOL JSM-7600F field emission 
SEM under vacuum (9.6 x 10-5 Pascal) with accelerating voltage of 1.00 kV. The scale 
bar is 1 µm. (A-B) 0 µg/mL (control), (C-D) 16.88 µg/mL, (E-F) 33.75 µg/mL pristine 
CNT exposure. Total magnification was 10,000x (A, C, E), 25,000x (B), and 20,000x (D, 
F).       
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Figure 20. Atomic force microscopy (AFM) images of E. coli K12 after 24 hour exposure 
to pristine CNTrene® C100LM using a 5.000 µm scan size. Three dimensional images 
from Veeco Dimension 3100 with a Nanoscope IIIA Controller using tapping mode and a 
silicon tip (radius of 8.0 nm) under atmospheric conditions. All images captured with a 
scan rate of 1.001 Hz and 512 samples. Data scale for all images was 2.000 µm with X 
position of -19783.4 µm and Y position of -42151.3 µm. (A) 0 µg/mL (control), (B) 1.05 
µg/mL, (C) 16.88 µg/mL, (D) 33.75 µg/mL pristine CNT exposure. 
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Figure 21. Atomic force microscopy (AFM) images of E. coli K12 after 24 hour exposure 
to pristine CNTrene® C100LM using a 20.00 µm scan size. Three dimensional images 
from Veeco Dimension 3100 with a Nanoscope IIIA Controller using tapping mode and a 
silicon tip (radius of 8.0 nm) under atmospheric conditions. All images captured with a 
scan rate of 1.001 Hz and 512 samples. Data scale for all images was 3.000 µm with X 
position of -19783.4 µm and Y position of -42151.3 µm. (A) 0 µg/mL (control), (B) 1.05 
µg/mL, (C) 16.88 µg/mL, (D) 33.75 µg/mL pristine CNT exposure.     
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Figure 22. Electropherograms and simulated gel images for total RNA samples extracted 
from E.coli K12 cultures.  Electropherograms and simulated gel images from Agilent 
Technologies 2100 Bioanalyzer system using 2100 Expert software. Simulated gel image 
of RNA ladder (L) [From top: 4000 nucleotides (nt), 2000 nt, 1000 nt, 500 nt, 200 nt, and 
25 nt] included for comparison to sample lanes (insets). Electropherograms illustrate 
fluorescence units (FU) against time in seconds for: (A) Control sample 1; (B) Control 
sample 2; (C) Control sample 3; (D) Pristine CNTrene® treatment (1.05 µg/mL) sample 
1; (E) Pristine CNTrene® C100LM treatment (1.05 µg/mL) sample 2; (F) Pristine 
CNTrene® C100LM treatment (1.05 µg/mL) sample 3.  
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Figure 23. Comparison of median gene expression in control and experimental data sets. 
Twenty six genes were ≥ 2-fold upregulated in CNT exposed cells, while 160 genes were 
≥ 2-fold downregulated in CNT exposed cell and 4128 genes did not have differential 
expression (R2 = 0.9643).  
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4 DISCUSSION 
 
4.1 Importance of Evaluation for CNT Products and Technology 
With the emergence of nanotechnology and the growing number of applications 
for carbon nanotubes, such as biosensors (Chen et al 2003; Wang et al. 2003; Yun et al 
2007; Huang et al. 2004; Timur et al 2007; Trojanowicz et al 2006) and vaccine/drug 
delivery systems (Bianco et al. 2005; Cai et al. 2005; Liu et al. 2007; Kam et al. 2005), it 
is important that the safety and potential impacts of nanoparticles on human health and 
environmental communities are fully evaluated. The potential cytotoxic effects on 
microbial communities is an important consideration during a chemical life cycle 
analysis, as these organisms play a vital role in environmental nutrient cycling, are 
essential for the maintenance of animal life, and play a role in health and disease. 
Consequently, disruption of the microbiota of an ecosystem has wide reaching 
consequences.  
 
4.2 MIC and Non-Lethal Effects  
In this study, the growth of E. coli K12 was not completely inhibited by either 
pristine or aged CNTrene® C100LM over the tested concentration range of 6.44 x 10-5 
µg/mL to 33.75 µg/mL under any of the growth conditions tested. Therefore, a MIC 
value after treatment with either pristine or aged CNTs was not observed. Growth curves 
for both pristine and aged CNTs overlaid with the corresponding controls without CNT 
exposure at all tested concentrations, regardless of media composition used. These data 
suggest that CNTrene® C100LM had no observable lethal or non-lethal effect on E. coli 
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K12 growth. Concentrations of CNTs greater than 1.05 µg/mL had a high initial optical 
density due to background interference from the black CNT solution, which made finding 
a linear portion of the growth curve difficult for determination of doubling time. 
Therefore, doubling times with CNT concentrations great than 1.05 µg/mL were not 
reliable and plate counts were used to determine viability.  Using plate counts, the 
cytotoxicity of concentrations of pristine CNTrene® between 8.44 µg/mL – 33.75 µg/mL 
was evaluated via a modified spot plate technique (Gaudy et. al., 1963). Although the cell 
number in CNT exposed cells appeared to be slightly lower than unexposed cells (t-test, p 
< 0.05), the difference in cell number was less than or equal to a 1.61-fold reduction in 
CFU/mL compared to the control at all CNT exposure concentrations. Moreover, a 
regression analysis suggests that these data do not significantly deviate from a slope of 
zero (p = 0.4031). These data imply that a there is no true biological difference in the 
slight reduction in CFU/mL when E. coli is exposed to up to 33.75 µg/mL CNTs.  
In addition to antibacterial plate counts, non-lethal growth effects of pristine 
CNTrene® C100LM at concentrations at and above 1.05 µg/mL were evaluated by 
electron microscopy. It is important to mention that during sample preparation, 
specifically the ethanol wash series, there was potential for losing small amounts of 
CNTs in the supernatant which could reduce the concentration of CNTs that were 
observed during visualization. Additionally, CNTs could be mechanically separated from 
the cell surface during centrifugation, despite the low g-force used to pellet the cells. This 
could also contribute to a reduction in CNT concentration in the final preparation. Yet, 
electron microscopy imaging of E. coli K12 revealed no observable morphological 
change between control cells and cells after 24 hour exposure to pristine CNTrene® 
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C100LM at concentrations up to 33.75 µg/mL. Furthermore, E. coli K12 cells showed no 
preference for attachment or aggregation to the CNT material, despite the tendency for 
bacterial cells to attach to surfaces and form biofilms or to aggregate with each other 
(Beloin et al 2008; Imuta et al. 2008). However, it would also be expected that negatively 
charged carboxyl functional groups on the sidewalls of CNTs would repel the net 
negative charge of bacterial cells, which likely accounts for the low level of observed 
association between cells and CNTs. This is in agreement with studies examining the 
cytotoxicity of fullerenes on bacteria. Fullerenes are a related carbon nanomaterial to 
CNTs, consisting of a cage-like sphere of carbon boned in hexagonal or pentagonal 
arrangements. So, CNTs can be considered a cylindrical form of a fullerene with similar 
surface and atomic structure and composition. In fullerenes, cationic functionalization 
(e.g. -NH2) is generally associated with increased cytotoxicity compared to anionic 
functionalization (e.g. -COOH) (Jensen et al 1996; Oberdörster etal 2005; Bosi et al 
2003). It is unsurprising that a similar trend would be observed for carboxyl 
functionalized SWCNTs as they are quite similar to fullerenes.  
The effect of pristine CNT exposure on the gene expression in E. coli K12 was 
evaluated by RNA sequencing and of the 4314 genes mapped, only three genes (pptA, 
alpA, and mgtL) were found to have significantly different expression levels. None of 
these differentially expressed genes are related to each other. It should be noted that the 
pptA gene had only a slight expression change of 2.5-fold down regulation in CNT 
exposed cells, just above the 2-fold change threshold. In contrast, the alpA and mgtL 
genes were highly differentially expressed at 35.1-fold down regulated and 85.3-fold 
upregulated, respectively. However, the role of these three genes is enigmatic because of 
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their unrelated cellular roles.  
The pptA gene encodes a putative 4-oxalocrotonate tautomerase and is implicated 
in degradation pathways for xenobiotic aromatic compounds (Whitman 2002; Almrud et. 
al. 2002). The slight down regulation of pptA (2.5-fold) is curious because the natural 
substrate is unknown. Furthermore, other genes involved in aromatic degradation 
pathways (i.e. mono-oxygenases) were not differentially expressed. This low level of 
regulation of pptA and an absence of regulation in genes that contribute to related 
pathways implies that the observed regulation may be due to sequencing bias, and not 
true regulation. Therefore, these expression levels should be confirmed by an alternative 
method, such as qPCR. 
The alpA gene is a regulatory gene for the cryptic prophage C4-57 and is part of 
the MerR superfamily of transcription regulators, which regulate in response to 
environmental stressors (Marchler-Bauer et al. 2015). Expression of alpA increases the 
expression of intA, encoding an integrase, which promotes excision of the CP4-57 cryptic 
prophage (Kirby et. al. 1994). Although no other genes involved in prophage 
maintenance were differentially expressed, the strong down regulation of alpA (35.1-fold) 
suggests that CNTrene® C100LM exposure may promote stable integration of the CP4-57 
cryptic prophage in the genome of E. coli K12. The alpA gene has also been implicated in 
a role in biofilm formation since its expression was 6.5-fold higher in E. coli lacking the 
autoinducer-2 transporter tqsA, which is induced in biofilms (Herzberg et. al. 2006). The 
regulation of phage genes has also been implicated in biofilm formation in Xylella 
fastidiosa (de Souza et al. 2004) and Pseudomonas aeruginosa (Webb et al. 2003). 
However, the role of phage-related genes in the formation of biofilms is currently 
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unknown. It is interesting to speculate that the down regulation of alpA is involved in 
down regulating biofilm formation, which may explain the lack of CNT-bacteria 
association as observed by SEM.  
The differential expression in the mgtL gene that acts as a Mg2+ porin leader 
sequence could serve as a potential sign of membrane stress as it acts as a riboswitch to 
promote Mg2+ uptake by promoting expression of the mgtA gene encoding the Mg2+ porin 
(Park et al. 2010). Although the mgtA leader had the highest regulation (85.3 up 
regulation), the transcript abundance of mgtA remained unchanged (1.0-fold expression 
change). This is likely due to the complex regulation of mgtA expression by both proline 
and Mg2+. Both low proline and low Mg2+ concentrations are required for transcription of 
mgtA (Park et al. 2010). However, the M9+B1 medium used contains an abundant supply 
of Mg2+ (i.e. 200 mM). Consequently, it is not surprising that an increase in mgtL did not 
influence mgtA expression.  
The lack of large changes in gene expression is not surprising given that growth 
was not significantly impacted by CNT exposure. However, it would be expected that 
gene regulation may play a role in normalizing growth behavior in CNT exposed cells. 
Yet, almost no gene regulation was seen and the few genes that were regulated were not 
differentially expressed to a large extent (i.e. > 100-fold). Interestingly, differential gene 
regulation has been previously reported to influence gene regulation. For example, CNT 
exposure to non-functionalized SWCNTs and MWCNTs was reported to activate genes 
associated with membrane and oxidative stress (Kang et al. 2008). Yet, no genes involved 
in these process were differentially expressed in CNTrene® C100LM exposed cells. 
Taken together, these data suggest that CNTrene® C100LM exposure does not cause cell 
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damage, death or influence growth. Furthermore, cells do not have a preference to adhere 
or associate with these CNTs, suggesting that exposure to even high levels of CNTrene® 
C100LM is innocuous to E. coli K12.   
 
4.3 Comparison to Current Studies on SWCNTs 
The findings of this study suggest exposure to the carboxyl functionalized 
SWCNT product CNTrene® C100LM does not negatively impact cell viability in E. coli 
K12, which is surprising given that many SWCNTs have been reported as having 
cytotoxic effects on various cell lines at and below treatment concentrations that were 
used in this study (Table 4). Current studies evaluating cytotoxic effects of CNTs on 
bacterial cells demonstrate the need for adequate characterization of the CNT materials 
tested, since physical and chemical properties of CNTs, including length, diameter, and 
functionalization, have shown an effect on cell viability observed in bacterial cells (Table 
4).  For example, CNTs with smaller diameters are generally more toxic than those with 
larger diameters (Kang et al 2008). Moreover, SWCNTs tend to be more toxic as their 
length increases (Yang et al. 2010).  
The in vitro effects of SWCNT on human dermal fibroblasts cell lines have 
demonstrated that the degree of functionalization has a distinct effect on observed 
cytotoxicity (Sayes et al. 2006). In human dermal fibroblasts, cytotoxicity decreases as 
the degree of phenylated functionalization increasing (Sayes et al. 2006). Similarly, it has 
been reported that surface functionalization has an impact on the observed cell viability 
in E. coli K12 cultures, though the decrease in cytotoxicity with functionalization was 
thought to be an indirect effect due to change in aggregation size (Pasquini et al. 2012). It 
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should be noted that the actual concentration of SWCNT exposure to cells used by 
Pasquini et al. 2012 was hard to determine since SWCNTs were coated on a PTFE 
membrane and E. coli K12 cells were filter onto this membrane for attachment. This 
creates an artificial interaction between cells and CNTs that would not otherwise be 
found in natural planktonic conditions or natural biofilm formation. Furthermore, heavy 
metal content of CNTs used in the study is unknown as it was not reported. Antimicrobial 
effects of non-functionalized SWCNTs have been reported in both gram negative and 
gram positive model organisms, with physical piercing of cellular membranes by 
individually dispersed SWCNTs being the observed mechanism of cytotoxicity. The 
presence of trace amounts of Co metal, used as a catalyst in CNT synthesis, up to 1.0 
µg/mL did not affect cytotoxicity (Liu et al. 2009). Other conditions, including 
surfactants used to suspend SWCNTs have also affect microbial cell viability and 
demonstrates that there are compounding factors when evaluating cytotoxicity of 
nanomaterials (Dong et al. 2011).  
It should be addressed that there are many contradictory findings about 
cytotoxicity of SWCNTs, which have been attributed to the variety of SWCNTs available 
including differences in purity and heavy metal content left over from CNT production 
(Yang et al. 2010). While some studies have found strong cytotoxic activity with 
SWCNTs that have carboxyl functionalization (Arias and Yang 2009), others have 
reported the opposite finding (Lewinski et al. 2008). Most studies examine cytotoxicity of 
SWCNTs that are artificially coated onto membranes by filtering cells through the 
membrane. This procedure can lead to an inflated CNT exposure concentration and 
forces a CNT-cell interaction that may not accurately reflect planktonic bacterial 
 58 
cytotoxicity or cytotoxicity in biofilms. Moreover, many cytotoxicity studies that do 
report CNTs as highly toxic in planktonic cell cultures only report toxicity associated 
with the CNT-cell aggregates (Kang et al 2008; Kang et al. 2007). This also artificially 
inflates toxicity because the majority of the cells are suspended and not in association 
with CNTs or CNT aggregates. For example, non-functionalized SWCNTs were reported 
to cause 80% loss of E. coli K12 viability in liquid cultures. However, this was only for 
SWCNT-bacterial aggregates, while the viability for cells in free suspension without 
CNT-association was only reduced by 8%. This was equivalent to the loss of viability of 
untreated cells (Kang et al. 2008). This suggests that a physical interaction is necessary 
for CNT cytotoxicity. Most cells grown in liquid culture are ‘free-swimming’ and not 
CNT-associated. Consequently, studies that only examine these associations and ignore 
the majority of the cells (i.e. in bulk solution) greatly overestimate the cytotoxic effect of 
the CNT in question. Due to the variation in reported effects and the variety of potential 
applications, it is imperative that the effects of each distinctive type of CNT and their 
characterization is adequately evaluated using standardized methods to obtain a clear 
picture of toxicity. 
 
4.4 Future Direction in Evaluating Bacterial Cytotoxicity of Nanoparticles 
This study included the use of RNA sequencing which compared the gene 
expression of E. coli K12 exposed to pristine CNTrene® C100LM to native gene 
expression. Future works for this study would include validation of RNA sequencing data 
with quantitative polymerase chain reaction (qPCR), which would provide confirmation 
of the gene expression data as to whether the regulatory trends observed in RNA 
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sequencing were legitimate trends or produced by artifacts in sequencing or library 
preparation. In addition, this work sets the foundation for future studies evaluating the 
cytotoxicity of various nanomaterials in both gram negative and gram positive bacteria, 
providing standard operating procedures and handling protocols for the various assays 
and techniques in the evaluation of microbial cytotoxicity.  
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